Search clinical trials for: 18F-DPA714

Total 1757 results

Hoffmann-La Roche

Completed

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Alzheimer's Disease, Healthy Volunteer

United States
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation (Neoafa)

Chemotherapy | Surgery | Non Small Cell Lung Cancer | EGFR Activating Mutation | EGFR TKI
Memorial Sloan Kettering Cancer Center

Completed

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Melanoma | Sarcoma | Lymphoma | Carcinoma | Myeloma

United States
National Taiwan University Hospital

Recruiting

Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism Syndromes

Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan

Taiwan
Radboud University Medical Center

Completed

Neuroinflammation in Cognitive Decline Post-cardiac Surgery (FOCUS)

Coronary Artery Disease | Postoperative Cognitive Dysfunction | Pathophysiology

Netherlands
Stanford University

Not yet recruiting

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Metastatic Breast Carcinoma | Female Breast Cancer
University of Alabama at Birmingham

Not yet recruiting

Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma

High Grade Glioma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Metastatic Prostate Cancer

United States
Centre Georges Francois Leclerc

Completed

A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC (IMKRUN 2)

Carcinoma, Non-Small-Cell Lung

France
Invicro

Completed

D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562

Healthy Male Volunteers

United States
David M. Schuster, MD

Terminated

FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer

Prostate Cancers

United States
Tammie L. S. Benzinger, MD, PhD

Withdrawn

Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers. (Protocol_Z)

Alzheimer Disease

United States
Peking University Cancer Hospital & Institute

Active, not recruiting

Research for the Molecular Imaging of the PD-L1 Targeting Tracer

Lung Cancer | Solid Tumor

China
University Medical Center Groningen

Recruiting

[18F]MC225-PET in Neurodegenerative Disease

Parkinson Disease | Neurodegenerative Diseases | Alzheimer Disease | Mild Cognitive Impairment

Netherlands
University Medical Center Groningen

Not yet recruiting

[18F]MC225 PET to Evaluate Gender Differences in BBB P-gp Function

Gender
Central Hospital, Nancy, France

Completed

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19 (TEP-COV)

Covid-19

France
Washington University School of Medicine
St. Louis Children's Hospital

Recruiting

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism (18FDOPA HI)

Hyperinsulinism

United States
Ottawa Hospital Research Institute

Unknown

Radionecrosis and FDG PET (DTPI FDG-PET)

Malignant Glioma

Canada
University of Washington
National Institute on Aging (NIA); Ellison Foundation

Not yet recruiting

University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core

Alzheimer Disease
University Hospital, Bordeaux

Completed

Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer (MISORL)

Head and Neck Neoplasms | Cancer of Head and Neck

France
Northwestern University
National Institute on Aging (NIA)

Recruiting

Tau PET Imaging in Atypical Dementias

Primary Progressive Aphasia With Suspected Alzheimer's Disease

United States
University of Zurich
Avid Radiopharmaceuticals; Swiss Federal Institute of Technology

Active, not recruiting

Imaging Tau Deposition in the Brain of Elderly Subjects (Add-Tau)

Healthy | Neurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
Abramson Cancer Center of the University of Pennsylvania

Completed

[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers

Gynecologic Cancer

United States
Hoag Memorial Hospital Presbyterian

Active, not recruiting

18F-fluoroestradiol (FES) PET/CT for Breast Cancer

Breast Cancer

United States
Amsterdam UMC, location VUmc

Completed

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET (FORESIGHT)

Breast Cancer

Netherlands
University of Aarhus

Recruiting

18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Denmark
University Health Network, Toronto
Canadian Cancer Society (CCS)

Completed

A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer

Hypoxia | Pancreatic Cancer

Canada
Leiden University Medical Center

Recruiting

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Urothelial Carcinoma | Sarcoma,Soft Tissue

Netherlands
Bital Savir-Baruch
Blue Earth Diagnostics

Unknown

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

Cervical Cancer | Ovarian Epithelial Cancer | Endometrial Cancer

United States
University of Utah

Terminated

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Brain Cancer

United States
Peking University Cancer Hospital & Institute

Recruiting

Research for the Molecular Imaging of the HER2 Targeting Tracer

HER2 Positive or Suspicious Positive Tumors

China
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (OSPREY)

Prostate Cancer

United States, Canada
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects (MK9470)

Parkinson Disease

United States
Institut Curie
Zionexa

Recruiting

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients (ECLECTIC)

Breast Carcinoma

France
Celgene

Completed

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Healthy Volunteers

Belgium
Julie L. Sutcliffe, Ph.D
National Cancer Institute (NCI)

Active, not recruiting

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Breast Carcinoma | Lung Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma | Metastatic Malignant Neoplasm in the Lung | Metastatic Malignant Neoplasm in the Breast | Metastatic Malignant Neoplasm in the Colon | Metastatic Malignant Neoplasm in the Rectum

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Blue Earth Diagnostics

Recruiting

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Prostate Cancer

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
St. Joseph's Healthcare Hamilton

Unknown

Integrated 18F-labelled PSMA Project

Prostate Cancer

Canada
Yale University
Pfizer; Avid Radiopharmaceuticals

Completed

Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

United States
University Ghent
Research Foundation Flanders; Special Research Fund, Belgium

Completed

PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?

High-grade Glioma of the Brain

Belgium
Hospices Civils de Lyon

Completed

(18)F-FDG PET Database of Adult Healthy Individuals (BDD-FDG)

Healthy

France
National Taiwan University Hospital

Unknown

The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
University Hospital, Tours

Completed

Neuroinflammation and Cognitive Decline in Alzheimer Disease (NICAD)

Alzheimer Disease

France
Abramson Cancer Center at Penn Medicine

Recruiting

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

United States
Nottingham University Hospitals NHS Trust

Completed

[18F]HX4 PET/CT Imaging for Detection of Hypoxia (OXYPET)

Head and Neck Cancer | Lung Cancer

United Kingdom
Aposense Ltd.

Unknown

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung

United States
Nantes University Hospital

Completed

18F-deoxyglucose (FDG) PET-CMD

Patients With Idiopathic Dilated Cardiomyopathy

France

Search clinical trials for: 18F-DPA714

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations